3439.60
4.17%
HDFC Securities
Revenue fell by 11.95% to Rs. 689.29 Cr in Q3FY17 when compared to the previous quarter. Also, it decreased by 5.63% when compared with Q3FY16.
GlaxoSmithKline Pharmaceuticals Ltd. is trading above all available SMAs
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended